EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare

Jan Geissler, Lydia E Makaroff, Bärbel Söhlke, Carsten Bokemeyer

European Journal of Cancer · 2023-11 · 193 · 113323

DOI: 10.1016/j.ejca.2023.113323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-11. Verfasst von Jan Geissler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Patvocates, München, Germany. Hauptthemen laut MEDLINE: Antineoplastic Agents, Medical Oncology, Neoplasms, Patient Participation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer Healthcare, Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMedical OncologyNeoplasmsPatient ParticipationPrecision MedicineTechnology Assessment, BiomedicalHumansEvidence-Based MedicineRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Health technology assessmentPatient accessPrecision oncologyReal world evidence

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Patvocates, München, Germany.
  • World Bladder Cancer Patient Coalition, Brussels, Belgium; Fight Bladder Cancer, Oxfordshire, UK.
  • Lung Cancer Patient, Düsseldorf, Germany.
  • University Medical Centre Hamburg Eppendorf, Hamburg, Germany. Electronic address: c.bokemeyer@uke.de.

Förderung

  • Bayer Healthcare
  • Bayer

Zitieren

APA

Geissler, J., Makaroff, L. E., Söhlke, B., & Bokemeyer, C. (2023). Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare. European Journal of Cancer, 193, 113323. https://doi.org/10.1016/j.ejca.2023.113323

Vancouver

Geissler J, Makaroff LE, Söhlke B, Bokemeyer C. Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare. European Journal of Cancer. 2023;193:113323. doi:10.1016/j.ejca.2023.113323

BibTeX
@article{Geissler2023,
  author = {Geissler, Jan and Makaroff, Lydia E and Söhlke, Bärbel and Bokemeyer, Carsten},
  title = {Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {193},
  pages = {113323},
  doi = {10.1016/j.ejca.2023.113323}
}
Kostenlos starten →